Clinical Trial Update: A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors [EARLY_Phase 1]

View source ↗

Summary

Phase 0 multicenter study evaluating pharmacodynamic effects of intratumoral microdosing with PBA-0111 in solid tumors; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Soft Tissue Sarcoma
• Triple-negative Breast Cancer

Drugs mentioned

• PBA-0111

Snippet

Sponsor: Pure Biologics S.A. | Conditions: Head and Neck Squamous Cell Carcinoma, Soft Tissue Sarcoma Adult | EARLY_Phase 1 | Status: RECRUITING